These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 17519649

  • 1. Dose-dependent constipation with higher doses of quetiapine: a case series.
    Raedler TJ, Reimer J, Wiedemann K.
    Int Clin Psychopharmacol; 2007 Jul; 22(4):244-6. PubMed ID: 17519649
    [Abstract] [Full Text] [Related]

  • 2. Quetiapine: efficacy, tolerability and safety in schizophrenia.
    Miodownik C, Lerner V.
    Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
    [Abstract] [Full Text] [Related]

  • 3. High-dose quetiapine and photopsia.
    Hazra M, Culo S, Mamo D.
    J Clin Psychopharmacol; 2006 Oct; 26(5):546-7. PubMed ID: 16974209
    [No Abstract] [Full Text] [Related]

  • 4. Does quetiapine have mood altering properties?
    Mishra A, Moore PB, Hobbs R.
    J Psychopharmacol; 2004 Jun; 18(2):281-4. PubMed ID: 15260919
    [Abstract] [Full Text] [Related]

  • 5. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
    Berger GE, Proffitt TM, McConchie M, Kerr M, Markulev C, Yuen HP, O'Donnell C, Lubman D, Polari A, Wood S, Amminger PG, McGorry PD.
    J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233
    [Abstract] [Full Text] [Related]

  • 6. Quetiapine in the treatment of psychotic adolescents: a case series of 23 patients with severe early onset psychosis.
    Beer F, Heinrich H, Springer S, Rüth U, Freisleder FJ.
    World J Biol Psychiatry; 2007 Nov; 8(1):38-41. PubMed ID: 17366348
    [Abstract] [Full Text] [Related]

  • 7. Seizures associated with quetiapine treatment.
    Dogu O, Sevim S, Kaleagasi HS.
    Ann Pharmacother; 2003 Sep; 37(9):1224-7. PubMed ID: 12921503
    [Abstract] [Full Text] [Related]

  • 8. Rapid initiation of quetiapine well tolerated as compared with the conventional initiation regimen in patients with schizophrenia or schizoaffective disorders.
    Hsiao CC, Chen KP, Tsai CJ, Wang LJ, Chen CK, Lin SK.
    Kaohsiung J Med Sci; 2011 Nov; 27(11):508-13. PubMed ID: 22005160
    [Abstract] [Full Text] [Related]

  • 9. High-dose loading with extended release quetiapine.
    Chae BJ.
    J Clin Pharm Ther; 2010 Aug; 35(4):487-9. PubMed ID: 20831551
    [Abstract] [Full Text] [Related]

  • 10. Quetiapine indication shift in the elderly: diagnosis and dosage in 208 psychogeriatric patients from 2000 to 2006.
    Hilwerling L, Juckel G, Schröder SG.
    Int J Geriatr Psychiatry; 2007 May; 22(5):401-4. PubMed ID: 17096460
    [Abstract] [Full Text] [Related]

  • 11. Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use.
    Philip NS, Mello K, Carpenter LL, Tyrka AR, Price LH.
    Ann Clin Psychiatry; 2008 May; 20(1):15-20. PubMed ID: 18297582
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release.
    Figueroa C, Brecher M, Hamer-Maansson JE, Winter H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar 17; 33(2):199-204. PubMed ID: 18948162
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
    Lee KU, Jeon YW, Lee HK, Jun TY.
    Hum Psychopharmacol; 2009 Aug 17; 24(6):447-52. PubMed ID: 19606454
    [Abstract] [Full Text] [Related]

  • 14. Rapid dose initiation of quetiapine for the treatment of acute schizophrenia and schizoaffective disorder: a randomised, multicentre, parallel-group, open study.
    Boidi G, Ferro M.
    Hum Psychopharmacol; 2007 Jul 17; 22(5):299-306. PubMed ID: 17487936
    [Abstract] [Full Text] [Related]

  • 15. Review of quetiapine side effects.
    Garver DL.
    J Clin Psychiatry; 2000 Jul 17; 61 Suppl 8():31-3; discussion 34-5. PubMed ID: 10811241
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders.
    Gerlach M, Hünnerkopf R, Rothenhöfer S, Libal G, Burger R, Clement HW, Fegert JM, Wewetzer Ch, Mehler-Wex C.
    Pharmacopsychiatry; 2007 Mar 17; 40(2):72-6. PubMed ID: 17447177
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study].
    Leweke FM, Gerth CW, Koethe D, Nolden BM, Klosterkötter J.
    Fortschr Neurol Psychiatr; 2007 Apr 17; 75(4):211-9. PubMed ID: 17230308
    [Abstract] [Full Text] [Related]

  • 18. Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting.
    Ketter TA, Brooks JO, Hoblyn JC, Holland AA, Nam JY, Culver JL, Marsh WK, Bonner JC.
    J Psychiatr Res; 2010 Oct 17; 44(14):921-9. PubMed ID: 20378127
    [Abstract] [Full Text] [Related]

  • 19. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia.
    Perez V, Cañas F, Tafalla M, TESIS Study Group.
    Int Clin Psychopharmacol; 2008 May 17; 23(3):138-49. PubMed ID: 18408528
    [Abstract] [Full Text] [Related]

  • 20. Quetiapine-induced obsessive-compulsive symptoms: a series of five cases.
    Stamouli S, Lykouras L.
    J Clin Psychopharmacol; 2006 Aug 17; 26(4):396-400. PubMed ID: 16855458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.